ITGAX and chronic myelomonocytic leukemia: We observed a significantly decreased frequency of cells in the cluster of CD4+ T cells (CD4 T1) and B cells in patients with CMML, with a corresponding increase in the frequency of myeloid cluster 2 monocytic cells, characterized by the expression of CD11c, CD14, and CD38 (Fig. 1D).